Detalhe da pesquisa
1.
Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity.
Nat Immunol
; 21(8): 914-926, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32424363
2.
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy.
Nature
; 629(8010): 201-210, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38600376
3.
Enterotoxins can support CAR T cells against solid tumors.
Proc Natl Acad Sci U S A
; 116(50): 25229-25235, 2019 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31767744
4.
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunity.
Cell Rep
; 42(8): 113014, 2023 08 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37605534
5.
Cellular networks controlling T cell persistence in adoptive cell therapy.
Nat Rev Immunol
; 21(12): 769-784, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33879873
6.
A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-cell Antitumor Effect Against Pancreatic Cancer.
Clin Cancer Res
; 27(22): 6222-6234, 2021 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34475103
7.
MAIT cells regulate NK cell-mediated tumor immunity.
Nat Commun
; 12(1): 4746, 2021 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34362900
8.
p38 Kinase: A Key Target for Driving Potent T Cells for Adoptive Immunotherapy.
Cancer Cell
; 37(6): 756-758, 2020 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32516586
9.
Enhancing chimeric antigen receptor T-cell immunotherapy against cancer using a nanoemulsion-based vaccine targeting cross-presenting dendritic cells.
Clin Transl Immunology
; 9(7): e1157, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32704371
10.
Genetic Redirection of T Cells for the Treatment of Pancreatic Cancer.
Front Oncol
; 9: 56, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30809507
11.
Tissue-specific tumor microenvironments influence responses to immunotherapies.
Clin Transl Immunology
; 8(11): e1094, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31768254
12.
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunity.
Cell Rep
; 43(2): 113793, 2024 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38324452
13.
Chimeric antigen receptor T cell therapies for thoracic cancers-challenges and opportunities.
J Thorac Dis
; 12(8): 4510-4515, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32944365